Remus Pharmaceuticals Limited (NSE:REMUS)
India flag India · Delayed Price · Currency is INR
961.65
+11.85 (1.25%)
Aug 21, 2026, 3:29 PM IST

Remus Pharmaceuticals Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
128.872.347.230.3811.49
Short-Term Investments
420.3200.4202.4--
Cash & Short-Term Investments
549.1272.7249.630.3811.49
Cash Growth
101.36%9.25%721.54%164.51%38.30%
Accounts Receivable
1,3981,0801,15348.4829.15
Receivables
1,4951,2901,33548.4829.15
Inventory
720.6515.6431.12.8715.89
Prepaid Expenses
-3.20.40.490.07
Other Current Assets
181.8131.9107.731.2220.34
Total Current Assets
2,9462,2142,123113.4476.94
Property, Plant & Equipment
17868.348.625.133.09
Long-Term Investments
2,5721,9531,064206.1630.68
Goodwill
87.387.387.3--
Other Intangible Assets
2.42.62.10.5-
Long-Term Deferred Tax Assets
---1.270.41
Other Long-Term Assets
0.31.25.90.1247.49
Total Assets
5,7874,3263,331346.61158.6

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
760.4712.9937.135.3146.73
Accrued Expenses
2414.610.48.612.75
Short-Term Debt
-171.283.46.38-
Current Portion of Long-Term Debt
173.73.62.12.160.93
Current Portion of Leases
10.15.15.1--
Current Income Taxes Payable
66.128.114.46.754.71
Other Current Liabilities
456.7279.8358.622.4136.71
Total Current Liabilities
1,4911,2151,41181.6291.84
Long-Term Debt
56.733.33070.890.99
Long-Term Leases
30.216.621.7--
Pension & Post-Retirement Benefits
-5.74.22.75-
Long-Term Deferred Tax Liabilities
325.1229111.6--
Other Long-Term Liabilities
6.210.4--
Total Liabilities
1,9091,5011,579155.2692.82

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
117.858.914.710.8510
Additional Paid-In Capital
-504.3504.741.65-
Retained Earnings
-571.9337.1138.8655.78
Comprehensive Income & Other
3,3921,424720.4--
Total Common Equity
3,5102,5591,577191.3665.78
Minority Interest
367.4266.9175.2--
Shareholders' Equity
3,8772,8261,752191.3665.78
Total Liabilities & Equity
5,7874,3263,331346.61158.6

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
270.7229.8142.379.431.92
Net Cash (Debt)
278.442.9107.3-49.059.57
Net Cash Growth
548.95%-60.02%--73.48%
Net Cash Per Share
29.503.649.50-6.001.20
Filing Date Shares Outstanding
9.3411.6611.788.688.68
Total Common Shares Outstanding
9.3411.6611.788.688.68
Working Capital
1,455998.4712.231.82-14.9
Book Value Per Share
375.66219.47133.8222.057.58
Tangible Book Value
3,4202,4691,488190.8565.78
Tangible Book Value Per Share
366.06211.76126.2321.997.58
Buildings
-3.33.33.28-
Machinery
-69.735.831.077.89
Construction In Progress
--0.10.22-